JP2010513478A5 - - Google Patents

Download PDF

Info

Publication number
JP2010513478A5
JP2010513478A5 JP2009542710A JP2009542710A JP2010513478A5 JP 2010513478 A5 JP2010513478 A5 JP 2010513478A5 JP 2009542710 A JP2009542710 A JP 2009542710A JP 2009542710 A JP2009542710 A JP 2009542710A JP 2010513478 A5 JP2010513478 A5 JP 2010513478A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
compound
indazol
copd
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009542710A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010513478A (ja
JP5119267B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2007/001136 external-priority patent/WO2008076048A1/en
Publication of JP2010513478A publication Critical patent/JP2010513478A/ja
Publication of JP2010513478A5 publication Critical patent/JP2010513478A5/ja
Application granted granted Critical
Publication of JP5119267B2 publication Critical patent/JP5119267B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009542710A 2006-12-21 2007-12-20 グルココルチコイド受容体介在障害の処置のためのインダゾリルエステルおよびアミド誘導体 Expired - Fee Related JP5119267B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US87118406P 2006-12-21 2006-12-21
US60/871,184 2006-12-21
US94174507P 2007-06-04 2007-06-04
US60/941,745 2007-06-04
US97852607P 2007-10-09 2007-10-09
US60/978,526 2007-10-09
PCT/SE2007/001136 WO2008076048A1 (en) 2006-12-21 2007-12-20 Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012184346A Division JP2012224647A (ja) 2006-12-21 2012-08-23 グルココルチコイド受容体介在障害の処置のためのインダゾリルエステルおよびアミド誘導体

Publications (3)

Publication Number Publication Date
JP2010513478A JP2010513478A (ja) 2010-04-30
JP2010513478A5 true JP2010513478A5 (enExample) 2012-10-11
JP5119267B2 JP5119267B2 (ja) 2013-01-16

Family

ID=39536557

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009542710A Expired - Fee Related JP5119267B2 (ja) 2006-12-21 2007-12-20 グルココルチコイド受容体介在障害の処置のためのインダゾリルエステルおよびアミド誘導体
JP2012184346A Pending JP2012224647A (ja) 2006-12-21 2012-08-23 グルココルチコイド受容体介在障害の処置のためのインダゾリルエステルおよびアミド誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012184346A Pending JP2012224647A (ja) 2006-12-21 2012-08-23 グルココルチコイド受容体介在障害の処置のためのインダゾリルエステルおよびアミド誘導体

Country Status (36)

Country Link
US (4) US7728030B2 (enExample)
EP (1) EP2102169B1 (enExample)
JP (2) JP5119267B2 (enExample)
KR (1) KR20090091354A (enExample)
CN (1) CN101611015B (enExample)
AR (1) AR064505A1 (enExample)
AU (1) AU2007334659B2 (enExample)
CA (1) CA2673277A1 (enExample)
CL (1) CL2007003804A1 (enExample)
CR (1) CR10875A (enExample)
CY (1) CY1113269T1 (enExample)
DK (1) DK2102169T3 (enExample)
DO (1) DOP2009000148A (enExample)
EA (1) EA016895B1 (enExample)
EC (1) ECSP099452A (enExample)
ES (1) ES2387584T3 (enExample)
GT (1) GT200900175A (enExample)
HR (1) HRP20120656T1 (enExample)
IL (1) IL198880A (enExample)
JO (1) JO2754B1 (enExample)
MA (1) MA31087B1 (enExample)
MX (1) MX2009006540A (enExample)
MY (1) MY153270A (enExample)
NO (1) NO20092723L (enExample)
NZ (1) NZ577186A (enExample)
PE (1) PE20081838A1 (enExample)
PL (1) PL2102169T3 (enExample)
PT (1) PT2102169E (enExample)
RS (1) RS52411B (enExample)
SA (1) SA07280740B1 (enExample)
SV (1) SV2009003305A (enExample)
TN (1) TN2009000250A1 (enExample)
TW (1) TWI417094B (enExample)
UY (1) UY30824A1 (enExample)
WO (1) WO2008076048A1 (enExample)
ZA (1) ZA200903654B (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH081035Y2 (ja) 1993-06-30 1996-01-17 伸夫 高橋 家庭用雑排水の処理装置
FR2866886B1 (fr) * 2004-02-26 2007-08-31 Sanofi Synthelabo Derives d'aryl-et d'heteroaryl-akylcarbamates, leur preparation et leur application en therapeutique
TW200829578A (en) 2006-11-23 2008-07-16 Astrazeneca Ab Chemical compounds 537
JO2754B1 (en) * 2006-12-21 2014-03-15 استرازينكا ايه بي Amylendazoleil derivatives for the treatment of glucocorticoid-mediated disorders
WO2009142588A1 (en) * 2008-05-20 2009-11-26 Astrazeneca Ab Combination of (a) a chemokine receptor 1 (ccr1) antagonist and (b) glucocorticoid receptor modulator
TWI445705B (zh) * 2008-05-20 2014-07-21 Astrazeneca Ab 經苯基及苯并二基取代之吲唑衍生物
WO2009142589A1 (en) * 2008-05-20 2009-11-26 Astrazeneca Ab Combination of (a) glucocorticoid receptor modulator and (b) a muscarinic antagonist
WO2009142568A1 (en) * 2008-05-20 2009-11-26 Astrazeneca Ab Combination of (a) glucocorticoid receptor modulator and (b) a b2-agonist
WO2010008341A1 (en) * 2008-07-16 2010-01-21 Astrazeneca Ab A combination of (a) glucocorticoid receptor modulator and (b) a muscarinic antagonist
WO2010138421A1 (en) * 2009-05-27 2010-12-02 Merck Sharp & Dohme Corp. HEXAHYDROCYCLOPENTYL[f]INDAZOLE REVERSED AMIDES AND DERIVATIVES AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS
WO2011119518A1 (en) * 2010-03-25 2011-09-29 Merck Sharp & Dohme Corp. Soluble guanylate cyclase activators
GB201016912D0 (en) 2010-10-07 2010-11-24 Astrazeneca Ab Novel combination
GB201021979D0 (en) 2010-12-23 2011-02-02 Astrazeneca Ab New compound
GB201021992D0 (en) 2010-12-23 2011-02-02 Astrazeneca Ab Compound
MX2013014566A (es) 2011-06-29 2014-09-25 Bayer Ip Gmbh Formas cristalinas de derivados de indozolilamida para el tratamiento de transtornos mediados por el receptor glucocorticoide.
EP3057426A4 (en) 2013-10-17 2017-03-29 Dow AgroSciences LLC Processes for the preparation of pesticidal compounds
KR20160075565A (ko) 2013-10-17 2016-06-29 다우 아그로사이언시즈 엘엘씨 살충성 화합물의 제조 방법
BR112016008070B8 (pt) 2013-10-17 2022-08-23 Dow Agrosciences Llc Compostos pesticidas, e seus processos de preparação
JP2016535010A (ja) 2013-10-17 2016-11-10 ダウ アグロサイエンシィズ エルエルシー 有害生物防除性化合物の製造方法
CN105636440A (zh) 2013-10-17 2016-06-01 美国陶氏益农公司 制备杀虫化合物的方法
EP3057430A4 (en) 2013-10-17 2017-09-13 Dow AgroSciences LLC Processes for the preparation of pesticidal compounds
CN105636446B (zh) 2013-10-17 2018-07-13 美国陶氏益农公司 制备杀虫化合物的方法
US9249122B1 (en) 2014-07-31 2016-02-02 Dow Agrosciences Llc Process for the preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine
EP3186229A4 (en) 2014-07-31 2018-01-10 Dow AgroSciences LLC Process for the preparation of 3-(3-chloro-1h-pyrazol-1-yl)pyridine
EP3174856A4 (en) 2014-07-31 2018-01-10 Dow AgroSciences LLC Process for the preparation of 3-(3-chloro-1h-pyrazol-1-yl)pyridine
WO2016028328A1 (en) 2014-08-19 2016-02-25 Dow Agrosciences Llc Process for the preparation of 3-(3-chloro-1h-pyrazol-1-yl)pyridine
JP2017528469A (ja) 2014-09-12 2017-09-28 ダウ アグロサイエンシィズ エルエルシー ３−（３−クロロ−１ｈ−ピラゾール−１−イル）ピリジンの調製方法
FR3026105B1 (fr) * 2014-09-24 2019-04-19 Greenpharma Composition contenant au moins un inhibiteur de certaines chimiokines, son procede d'obtention et son utilisation dermocosmetique ou pharmaceutique
CN107001320B (zh) * 2014-09-26 2019-09-20 阿斯利康(瑞典)有限公司 1-烷基-6-氧代-1,6-二氢吡啶-3-基化合物及其用途
KR20180050408A (ko) 2015-09-15 2018-05-14 레오 파마 에이/에스 국부 약물 전달용의 비스테로이드성 글루코코르티코이드 수용체 조절제
WO2017161518A1 (en) 2016-03-23 2017-09-28 Astrazeneca Ab New physical form
US10100033B2 (en) 2016-12-29 2018-10-16 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds
WO2018125817A1 (en) 2016-12-29 2018-07-05 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds
CN111556867A (zh) 2017-12-18 2020-08-18 格吕伦塔尔有限公司 经取代的吡咯烷酰胺i
TW201927769A (zh) * 2017-12-18 2019-07-16 德商歌林達有限公司 經取代之吡咯啶醯胺ｉｉ
CN113382990B (zh) 2019-01-11 2024-11-19 格吕伦塔尔有限公司 取代的吡咯烷酰胺iii
CA3123490A1 (en) 2019-01-22 2020-07-30 Akribes Biomedical Gmbh Selective glucocorticoid receptor modifiers for treating impaired skin wound healing
EP3986886A2 (en) 2019-06-19 2022-04-27 Grünenthal GmbH Substituted pyrrolidine amides v
EP3986885B1 (en) 2019-06-19 2023-05-03 Grünenthal GmbH Substituted pyrrolidine amides iv
US12545648B2 (en) 2019-12-31 2026-02-10 Medshine Discovery Inc. Benzopyrazole compound
EP4178954B1 (en) 2020-07-09 2025-11-19 Grünenthal GmbH Substituted pyrrolidine amines and amides as mediator of the glucocortoid receptor
US20240246985A1 (en) * 2021-06-28 2024-07-25 Medshine Discovery Inc. Crystal form of triazolopyridine-substituted indazole compound and preparation method therefor
KR102571432B1 (ko) * 2023-02-08 2023-08-29 주식회사 에스씨엘테라퓨틱스 인다졸릴에스테르 및 아미드 유도체를 포함하는 암 치료용 조성물

Family Cites Families (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992441A (en) * 1972-12-26 1976-11-16 Pfizer Inc. Sulfamylbenzoic acids
DE3000377A1 (de) 1980-01-07 1981-07-09 Boehringer Mannheim Gmbh, 6800 Mannheim Neue sulfonamide, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE3514696A1 (de) 1985-04-24 1986-11-06 Bayer Ag, 5090 Leverkusen N-indolylethyl-sulfonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung
DE3535167A1 (de) * 1985-10-02 1987-04-09 Boehringer Mannheim Gmbh Neue sulfonyl-phenyl(alkyl)amine, verfahren zu ihrer herstellung sowie arzneimittel
DE3632329A1 (de) 1986-09-24 1988-03-31 Bayer Ag Substituierte phenylsulfonamide
TW224462B (enExample) 1992-02-24 1994-06-01 Squibb & Sons Inc
NZ247440A (en) 1992-05-06 1995-04-27 Squibb & Sons Inc Phenyl sulphonamide derivatives, preparation and pharmaceutical compositions thereof
CA2114981A1 (en) 1993-02-09 1994-08-10 Kazumi Ogata Quinolonecarboxylic acid derivatives
DE4323916A1 (de) 1993-07-16 1995-01-19 Basf Ag Substituierte 2-Phenylpyridine
WO1995003279A1 (en) 1993-07-26 1995-02-02 Eisai Co., Ltd. Sulfonamide and sulfonic ester derivatives each having tricyclic hetero ring
GB9504854D0 (en) * 1994-03-31 1995-04-26 Zeneca Ltd Nitrogen derivatives
US5545669A (en) 1994-06-02 1996-08-13 Adams; Jerry L. Anti-inflammatory compounds
GB9417532D0 (en) 1994-08-31 1994-10-19 Zeneca Ltd Aromatic compounds
AU5772296A (en) 1995-05-19 1996-11-29 Chiroscience Limited 3,4-disubstituted-phenylsulphonamides and their therapeutic use
TW523506B (en) 1996-12-18 2003-03-11 Ono Pharmaceutical Co Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients
TW542822B (en) 1997-01-17 2003-07-21 Ajinomoto Kk Benzamidine derivatives
ZA9811898B (en) 1997-12-29 2000-06-28 Ortho Mcneil Pharm Inc Anti-Inflammatory Compounds.
WO1999038845A1 (en) 1998-01-29 1999-08-05 Tularik Inc. Ppar-gamma modulators
DE19856475A1 (de) * 1998-11-27 2000-05-31 Schering Ag Nichtsteroidale Entzündungshemmer
WO2001024786A1 (en) 1999-05-13 2001-04-12 Shionogi & Co., Ltd. Preventive or therapeutic drugs for diabetes
US6569885B1 (en) 1999-12-23 2003-05-27 Icos Corporation Cyclic AMP-specific phosphodiesterase inhibitors
DE60106954T2 (de) 2000-09-11 2005-12-01 Pfizer Products Inc., Groton Resorcin-derivate
FR2815030A1 (fr) 2000-10-05 2002-04-12 Lipha Derives nitroso de la diphenylamine, compositions pharmaceutiques les contenant et leur utilisation pour la preparation de medicaments
JP2005507922A (ja) * 2001-09-19 2005-03-24 ファルマシア・コーポレイション 炎症の治療のための置換されたインダゾール化合物
AU2002334733B2 (en) 2001-10-01 2006-11-23 Arena Pharmaceuticals, Inc. MCH receptors antagonists
RU2004118719A (ru) 2001-11-22 2005-03-27 Оно Фармасьютикал Ко., Лтд. (Jp) Производные пиперидин-2-она и фармацевтические композиции, содержащие такие соединения в качестве активного ингредиента
ES2306880T3 (es) 2002-03-13 2008-11-16 Janssen Pharmaceutica Nv Derivados de sulfonilamino como inhibidores novedosos de la histona desacetilasa.
AU2003221706B2 (en) 2002-04-11 2008-02-28 Merck Sharp & Dohme Corp. 1H-Benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators
EP2399903A1 (en) 2002-05-24 2011-12-28 Millennium Pharmaceuticals, Inc. Ccr9 inhibitors and methods of use thereof
NL1021182C2 (nl) * 2002-07-30 2004-02-03 Xpar Vision B V Analysesysteem en werkwijze voor het analyseren en controleren van een productieproces voor glasproducten.
US20050113450A1 (en) 2002-08-23 2005-05-26 Atli Thorarensen Antibacterial agents
JP4619786B2 (ja) * 2002-08-29 2011-01-26 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 炎症性、アレルギー性及び増殖性疾患の治療において糖質コルチコイドミメティックスとして使用するための３−（スルホンアミドエチル）−インドール誘導体
US6894061B2 (en) 2002-12-04 2005-05-17 Wyeth Substituted dihydrophenanthridinesulfonamides
CA2515780C (en) 2003-02-20 2012-12-11 Encysive Pharmaceuticals Inc. Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists
GB0308466D0 (en) 2003-04-11 2003-05-21 Novartis Ag Organic compounds
US20040235892A1 (en) * 2003-05-22 2004-11-25 Yujia Dai Indazole and benzisoxazole kinase inhibitors
US7297709B2 (en) * 2003-05-22 2007-11-20 Abbott Laboratories Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
EP1635800A2 (en) 2003-06-10 2006-03-22 Kalypsys, Inc. Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease
WO2005004810A2 (en) 2003-07-02 2005-01-20 Merck & Co., Inc. Arylsulfonamide derivatives
BRPI0417687A (pt) 2003-12-19 2007-04-03 Pfizer derivados de benzenossulfonilamino-piridin-2-ila e compostos relacionados como inibidores de 11-beta-hidroxiesteróide desidrogenase tipo 1 (11-beta-hsd-1) para o tratamento de diabetes e obesidade
JP2005263787A (ja) 2004-02-17 2005-09-29 Ishihara Sangyo Kaisha Ltd アミド系化合物又はその塩、並びにそれらを含有するサイトカイン産生抑制剤
US20050250820A1 (en) 2004-03-08 2005-11-10 Amgen Inc. Therapeutic modulation of PPARgamma activity
DE102004028862A1 (de) * 2004-06-15 2005-12-29 Merck Patent Gmbh 3-Aminoindazole
CA2584413A1 (en) * 2004-10-29 2006-05-04 Astrazeneca Ab Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases
SE0402635D0 (sv) * 2004-10-29 2004-10-29 Astrazeneca Ab Chemical compounds
US8093281B2 (en) * 2005-04-14 2012-01-10 Glaxo Group Limited Indazoles as glucocorticoid receptor ligands
MX2007014811A (es) * 2005-06-10 2008-02-14 Boehringer Ingelheim Int Mimeticos de glucocorticoides, metodos para su fabricacion, composiciones farmaceuticas y usos de los mismos.
US7888381B2 (en) 2005-06-14 2011-02-15 Bristol-Myers Squibb Company Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity, and use thereof
TW200815361A (en) 2005-10-20 2008-04-01 Astrazeneca Ab Chemical compounds
GB0522880D0 (en) 2005-11-09 2005-12-21 Glaxo Group Ltd Novel compounds
US20090170898A1 (en) * 2006-03-31 2009-07-02 Malena Bengtsson Sulphonamide Derivatives as Modulators of the Glucocorticoid Receptor
KR20090003349A (ko) * 2006-04-20 2009-01-09 글락소 그룹 리미티드 화합물
KR20090020694A (ko) 2006-07-14 2009-02-26 일라이 릴리 앤드 캄파니 글루코코르티코이드 수용체 조절제 및 이의 사용 방법
GB0620385D0 (en) 2006-10-13 2006-11-22 Glaxo Group Ltd Novel compounds
GB0620406D0 (en) 2006-10-13 2006-11-22 Glaxo Group Ltd Novel compounds
MX2009004385A (es) 2006-10-23 2009-05-22 Merck & Co Inc Derivados de 2-[1-fenil-5-hidroxi-4alfa-metil-hexahidrociclopenta [f]indazol-5-il]etil fenilo como ligandos del receptor glucocorticoide.
CN101573340A (zh) 2006-11-01 2009-11-04 百时美施贵宝公司 糖皮质激素受体AP-1和/或NF-κB活性的调节剂及其用途
US8067447B2 (en) 2006-11-01 2011-11-29 Bristol-Myers Squibb Company Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
TW200829578A (en) 2006-11-23 2008-07-16 Astrazeneca Ab Chemical compounds 537
MX2009005264A (es) 2006-12-06 2009-05-28 Boehringer Ingelheim Int Mimeticos de glucocorticoides, metodos para su fabricacion, composiciones farmaceuticas y usos de los mismos.
JO2754B1 (en) 2006-12-21 2014-03-15 استرازينكا ايه بي Amylendazoleil derivatives for the treatment of glucocorticoid-mediated disorders
WO2008079073A1 (en) 2006-12-22 2008-07-03 Astrazeneca Ab Indazolyl sulphonamide derivatives for the treatment of glucocorticoid receptor mediated disorders
WO2008124745A1 (en) 2007-04-10 2008-10-16 Boehringer Ingelheim International Gmbh Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
JP2010523689A (ja) 2007-04-10 2010-07-15 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング グルココルチコイドミメティックス、その製造方法、医薬組成物及びその使用
GB0708858D0 (en) 2007-05-08 2007-06-13 Glaxo Group Ltd Novel compounds
GB0720557D0 (en) 2007-10-19 2007-11-28 Glaxo Group Ltd Novel compounds
GB0720546D0 (en) 2007-10-19 2007-11-28 Glaxo Group Ltd Novel compounds
GB0720544D0 (en) 2007-10-19 2007-11-28 Glaxo Group Ltd Novel compounds
GB0720556D0 (en) 2007-10-19 2007-11-28 Glaxo Group Ltd Novel compounds
GB0720549D0 (en) 2007-10-19 2007-11-28 Glaxo Group Ltd Novel compounds
GB0722211D0 (en) 2007-11-12 2007-12-27 Glaxo Group Ltd Novel compounds
GB0724254D0 (en) 2007-12-12 2008-01-23 Glaxo Group Ltd Novel compounds
CA2714607A1 (en) 2008-02-26 2009-09-03 Merck Sharp & Dohme Corp. Hexahydrocyclopentyl[f]indazole carboxamides and derivatives thereof as selective glucocorticoid receptor modulators
AU2009220458A1 (en) 2008-03-06 2009-09-11 Merck Sharp & Dohme Corp. Hexahydrocyclopentyl[f]findazole sulfonamides and derivates thereof as selective glucocorticoid receptor modulators
TWI445705B (zh) 2008-05-20 2014-07-21 Astrazeneca Ab 經苯基及苯并二基取代之吲唑衍生物
WO2010008341A1 (en) * 2008-07-16 2010-01-21 Astrazeneca Ab A combination of (a) glucocorticoid receptor modulator and (b) a muscarinic antagonist

Similar Documents

Publication Publication Date Title
JP2014515013A5 (enExample)
JP2013509429A5 (enExample)
JP2013525444A5 (enExample)
CN103717571B8 (zh) 9‑氨基甲基取代的四环素类化合物
JP2015525757A5 (enExample)
WO2011005811A8 (en) Combination therapy for the treatment of diabetes
JP2009502743A5 (enExample)
JP2013519675A5 (enExample)
JP2013542247A5 (enExample)
EP2749277A3 (en) Combination of glycopyrronium and vilanterol
CN109982699A (zh) 一种mor激动剂与kor激动剂的药物组合物及其用途
JP2012255026A5 (enExample)
JP2012532874A5 (enExample)
CN110036005A (zh) 酰胺衍生物及其在药物中的应用
JP2012502885A5 (enExample)
JP2009545527A5 (enExample)
JP2012507535A5 (enExample)
JP2013507408A5 (enExample)
WO2006082523A3 (en) Pharmaceutical sustained release composition of metformin
EP2085396A3 (en) Novel crystalline forms of tiotropium bromide
IL186374A (en) Combined use of prostaglandin compound and ppi for the manufacture of pharmacological compounds for the treatment of gastrointestinal disorders and pharmaceutical compounds containing them
WO2009140341A3 (en) Atorvastatin compositions
WO2008104852A3 (en) Pharmaceutical compositions comprising adsorbate of fenofibrate
JP2016515550A5 (enExample)
JP2009532434A5 (enExample)